Filing Details
- Accession Number:
- 0001179110-12-012533
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-08-07 19:03:11
- Reporting Period:
- 2012-08-03
- Filing Date:
- 2012-08-07
- Accepted Time:
- 2012-08-07 19:03:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1080014 | Theravance Inc | THRX | Pharmaceutical Preparations (2834) | 943265960 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1302445 | L David Brinkley | Theravance, Inc. 901 Gateway Boulevard South San Francisco CA 94080 | Head Of Business Dev. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-08-03 | 91,667 | $6.15 | 175,608 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-08-03 | 15,090 | $18.37 | 190,698 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-08-03 | 123,917 | $27.92 | 66,781 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2012-08-03 | 91,667 | $0.00 | 91,667 | $6.15 |
| Common Stock | Common Stock (Right to Buy) | Disposition | 2012-08-03 | 15,090 | $0.00 | 15,090 | $18.37 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 8,333 | 2018-11-30 | No | 4 | M | Direct | |
| 0 | 2015-02-09 | No | 4 | M | Direct |
Footnotes
- Dispositions made pursuant to a plan intended to comply with rule 10b5-1(c).
- This transaction was executed in multiple trades at prices ranging from $27.53 to $28.21. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- Immediately exercisable.
Billionaire Hedge Funds
